Autism Speaks Funds Studies of ASD Biomarkers, Predisposition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Autism Speaks' most recent round of research funding, totaling $13.2 million, includes grants for projects that delve into molecular, genetic, and epigenetic factors that may be involved in autism spectrum disorder.

Alongside its Basic and Clinical research program grant, the non-profit said yesterday that it also has funded projects through the new Translational Postdoctoral Fellowship program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.